Meridianins, a new family of protein kinase inhibitors isolated from the Ascidian Aplidium meridianum
- 18 February 2004
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (7), 1703-1707
- https://doi.org/10.1016/j.bmcl.2004.01.050
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammationMedicinal Research Reviews, 2002
- Designing Inhibitors of Cyclin-Dependent KinasesAnnual Review of Pharmacology and Toxicology, 2002
- Protein kinases — the major drug targets of the twenty-first century?Nature Reviews Drug Discovery, 2002
- Simple indole alkaloids and those with a nonrearranged monoterpenoid unitNatural Product Reports, 2001
- Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrestOncogene, 2001
- Protein kinase inhibitors: emerging pharmacophores 1997 - 2000Expert Opinion on Therapeutic Patents, 2001
- Marine natural products (1999)Natural Product Reports, 2001
- Indole Alkaloids from the Tunicate Aplidium meridianumJournal of Natural Products, 1998
- The Luffarins (A-Z), Novel Terpenes From an Australian Marine Sponge, Luffariella geometricaAustralian Journal of Chemistry, 1992
- A brominated (aminoimidazolinyl)indole from the sponge Discodermia polydiscusThe Journal of Organic Chemistry, 1991